NCT03145350

Brief Summary

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease in the world. It is currently unclear why fat starts to accumulate in the liver, although both the amount and type of food consumed have been implicated. The majority of studies that have investigated the effects of dietary fat or sugar on liver fat have fed volunteers excess calories, which are known to increase liver fat. The effect of specific dietary components, when consumed as part of a diet not containing excess calories, on liver fat accumulation remains unclear.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 9, 2017

Completed
4 months until next milestone

First Posted

Study publicly available on registry

May 9, 2017

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
Last Updated

March 27, 2020

Status Verified

May 1, 2018

Enrollment Period

3 years

First QC Date

January 9, 2017

Last Update Submit

March 26, 2020

Conditions

Keywords

NAFLDFat intakeSugar intake

Outcome Measures

Primary Outcomes (1)

  • Change in liver fat content

    Investigators will measure the change in liver fat content after each of the 4 week intervention diets by magnetic resonance imaging/spectroscopy (MRI/S).

    Before, and within 7 days after completion of each dietary intervention

Secondary Outcomes (3)

  • Change in hepatic fatty acid partitioning

    Within 7 days after completion of each dietary intervention

  • Change in plasma metabolite concentrations

    Before, and within 7 days after completion of each dietary intervention.

  • Change in whole-body fatty acid oxidation

    Within 7 days after completion of each dietary intervention

Study Arms (2)

High-fat, low-carbohydrate diet

ACTIVE COMPARATOR

Dietary intervention: Participants will consume a diet that is rich in saturated fat (20% total energy) and low in free sugars for 4 weeks. This diet will include commonly eaten foods such as butter, cheese, and fatty meat products. Total fat intake in this intervention will be 40-45% total energy.

Other: High-fat, low-carbohydrate

Low-fat, high-carbohydrate diet

ACTIVE COMPARATOR

Dietary intervention: Participants will consume a diet that is low in saturated fat (\~5% total energy) and rich in free sugars (20% total energy).The diet will include commonly eaten food and drink such as sugar sweetened beverages, confectionery (e.g. fruit gums) and table sugar.

Other: Low-fat, high-carbohydrate

Interventions

Dietary intervention: 4 week

High-fat, low-carbohydrate diet

Dietary intervention: 4 week

Low-fat, high-carbohydrate diet

Eligibility Criteria

Age30 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participant is willing and able to give informed consent for participation in the study.
  • BMI \>25 \<35kg/m2
  • No medical condition or relevant drug therapy known to affect liver, lipid or glucose metabolism

You may not qualify if:

  • Age \<30 or \>65 years
  • Body mass index \<25 or \>35kg/m2
  • A blood haemoglobin \<120mg/dL
  • Any metabolic condition or relevant drug therapy
  • People who do not tolerate fructose
  • Smoking
  • History of alcoholism or a greater than recommended alcohol intake
  • Pregnant or nursing mothers
  • Women prescribed any contraceptive agent or device including oral contraceptives, hormone replacement therapy (HRT) or who have used these within the last 12 months
  • History of severe claustrophobia
  • Presence of metallic implants, pacemaker
  • Haemorrhagic disorders
  • Anticoagulant treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oxford Centre for Diabetes, Endocrinology and Metabolism

Oxford, OX3 7LE, United Kingdom

Location

Related Publications (1)

  • Parry SA, Rosqvist F, Mozes FE, Cornfield T, Hutchinson M, Piche ME, Hulsmeier AJ, Hornemann T, Dyson P, Hodson L. Intrahepatic Fat and Postprandial Glycemia Increase After Consumption of a Diet Enriched in Saturated Fat Compared With Free Sugars. Diabetes Care. 2020 May;43(5):1134-1141. doi: 10.2337/dc19-2331. Epub 2020 Mar 12.

MeSH Terms

Conditions

Fatty LiverNon-alcoholic Fatty Liver Disease

Interventions

Diet, Fat-Restricted

Condition Hierarchy (Ancestors)

Liver DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Leanne Hodson, PhD

    University of Oxford

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
PI,and research assistants undertaking measurements will be blinded to the dietary intervention the participant is undertaking.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Randomised crossover with washout period.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2017

First Posted

May 9, 2017

Study Start

December 1, 2016

Primary Completion

December 1, 2019

Study Completion

March 1, 2020

Last Updated

March 27, 2020

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will share

Following completion of the study, all individual data obtained from participants may potentially be shared with other researchers, both here in the United Kingdom and abroad, in appropriate circumstances. If data is to be shared with other researchers, it will be done so under fully anonymised conditions.

Locations